112 related articles for article (PubMed ID: 6276645)
1. [A new preparation for peripheral arterial occlusive diseases].
Knüchel F
Med Welt; 1982 Jan; 33(1):90. PubMed ID: 6276645
[No Abstract] [Full Text] [Related]
2. [Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
Spinella G; Majorana M
Clin Ter; 1983 Mar; 104(5):375-81. PubMed ID: 6303677
[No Abstract] [Full Text] [Related]
3. [Clinical and instrumental evaluation of patients with chronic peripheral arterial occlusive disease after prolonged administration of suloctidil].
Gregoratti L; Redaelli G; Limido P; Ghiringhelli L
Clin Ter; 1982 Sep; 102(6):607-19. PubMed ID: 6291844
[No Abstract] [Full Text] [Related]
4. Intermittent claudication: Suloctidil v.s. placebo treatment.
Holm J; Lindblad L; Scherstén T; Suurkula M
Vasa; 1984; 13(2):175-8. PubMed ID: 6331019
[No Abstract] [Full Text] [Related]
5. [Medium term treatment with suloctidil in obliterating arteriopathies of the lower limbs. Personal experience].
Marongiu G; Dettori G; Gadeddu A; Noya G; Angius P; Biglioli P
Minerva Cardioangiol; 1983; 31(7-8):407-10. PubMed ID: 6316206
[No Abstract] [Full Text] [Related]
6. [Hemorrheological survey in a group with arteriosclerotic vascular disease treated with suloctidil].
Caimi G; Catania A; Frazzetta F; Capobianco D; Francavilla G; Romano A; Sarno A
Ric Clin Lab; 1983; 13 Suppl 3():465-8. PubMed ID: 6324326
[TBL] [Abstract][Full Text] [Related]
7. Controlled trial of suloctidil in intermittent claudication.
Verhaeghe R; Van Hoof A; Beyens G
J Cardiovasc Pharmacol; 1981; 3(2):279-86. PubMed ID: 6166799
[TBL] [Abstract][Full Text] [Related]
8. A double-blind trial of suloctidil v. placebo in intermittent claudication.
Jones NA; De Haas H; Zahavi J; Kakkar VV
Br J Surg; 1982 Jan; 69(1):38-40. PubMed ID: 6274471
[TBL] [Abstract][Full Text] [Related]
9. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
[No Abstract] [Full Text] [Related]
10. [Current EMNID survey on peripheral arterial occlusive disease].
Krankenpfl J; 2002; 40(7-9):217. PubMed ID: 12514861
[No Abstract] [Full Text] [Related]
11. A double-blind study comparing suloctidil and placebo in chronic peripheral arteriopathy.
Gillot P
Curr Ther Res Clin Exp; 1976 Nov; 20(5):637-44. PubMed ID: 825349
[No Abstract] [Full Text] [Related]
12. Medical treatment of intermittent claudication: a comparative double-blind study of suloctidil, dihydroergotoxine and placebo.
Adriaensen H
Curr Med Res Opin; 1976; 4(6):395-401. PubMed ID: 793778
[TBL] [Abstract][Full Text] [Related]
13. [Effect of papaveroline on chronic, obliterating, peripheral arterial diseases].
Sironi G; Benedetti G
Minerva Cardioangiol; 1973 Apr; 21(4):257-63. PubMed ID: 4710122
[No Abstract] [Full Text] [Related]
14. Peripheral arterial disease: drug therapy.
Schwartz JB
J Gend Specif Med; 2002; 5(4):16-20. PubMed ID: 12192882
[No Abstract] [Full Text] [Related]
15. [Beta blockers and peripheral blood circulation. Can the restrictions for indication still be maintained?].
Diehm C
MMW Munch Med Wochenschr; 1983 Jan; 125(2):27-8. PubMed ID: 6132334
[No Abstract] [Full Text] [Related]
16. [Effects of metoprolol on the peripheral circulation in patients with peripheral vascular disease].
Diehm C; Mörl H; Schettler G
Z Kardiol; 1983 Jan; 72(1):44-7. PubMed ID: 6837085
[TBL] [Abstract][Full Text] [Related]
17. [Effectiveness of Dusodril-Pi in arterial occlusive diseases. A multicentric double-blind study].
Becker HM; Elert O; Häring R; Maurer PC; Raithel D; Sperling M; Stockmann U; Storz LW; Hirche H
Med Welt; 1979 Oct; 30(43):1602-6. PubMed ID: 514039
[No Abstract] [Full Text] [Related]
18. [Double-blind study on piribedil in peripheral arterial diseases].
Milliken JC; Fares CM; O'Connor D
Minerva Med; 1976 May; 67(25):1662-7. PubMed ID: 778668
[No Abstract] [Full Text] [Related]
19. [Role of the blood platelets in the atherosclerotic process and clinical use of a new drug, Suloctidil, with anti-aggregating activity].
Armani U; Piana A
Arch Maragliano Patol Clin; 1979; 35(2):57-62. PubMed ID: 233645
[No Abstract] [Full Text] [Related]
20. [Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].
MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974333
[No Abstract] [Full Text] [Related]
[Next] [New Search]
